Interferon-inducible protein IFIXα inhibits cell invasion by upregulating the metastasis suppressor maspin

Molecular Carcinogenesis

Volumn 47, Issue 10, 2008, Pages 739-743

  Yamaguchi, Hirohito ^a   Ding, Yi ^a,b   Lee, Jin Fong ^a   Zhang, Ming ^b   Pal, Ashutosh ^a   Bornmann, William ^a   Yan, Duen Hwa ^a   Hung, Mien Chie ^a,c  

^a UNIVERSITY OF TEXAS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Breast cancer; HDAC1; IFIX ; Maspin

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; INTERFERON INDUCIBLE PROTEIN IFIXALPHA; MASPIN; MESSENGER RNA; PROTEASOME INHIBITOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; HISTONE DEACETYLASE; NUCLEAR PROTEIN; PYHIN1 PROTEIN, HUMAN; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL INVASION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TRANSACTIVATION; UPREGULATION; ANIMAL; APOPTOSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE SILENCING; GENETICS; MOUSE; PHYSIOLOGY;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; GENE SILENCING; HISTONE DEACETYLASES; HUMANS; MICE; NEOPLASM METASTASIS; NUCLEAR PROTEINS; RNA, MESSENGER; SERPINS; UP-REGULATION;

EID: 52649088367     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20423     Document Type: Article

References (20)

1. Ludlow LE, Johnstone RW, Clarke CJ. The HIN-200 family: More than interferon-inducible genes? Exp Cell Res 2005;308:1-17.
2. Johnstone RW, Trapani JA. Transcription and growth regulatory functions of the HIN-200 family of proteins. Mol Cell Biol 1999;19:5833-5838.
3. Ding Y, Wang L, Su LK, et al. Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer. Oncogene 2004;23:4556-4566.
4. Khalkhali-Ellis Z. Maspin: The new frontier. Clin Cancer Res 2006;12:7279-7283.
5. Bailey CM, Khalkhali-Ellis Z, Seftor EA, Hendrix MJ. Biological functions of maspin. J Cell Physiol 2006;209:617-624.
6. Zhang M. Multiple functions of maspin in tumor progression and mouse development. Front Biosci 2004;9:2218-2226.
7. Lockett J, Yin S, Li X, Meng Y, Sheng S. Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem 2006;97:651-660.
8. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-529.
9. Shi HY, Zhang W, Liang R, et al. Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res 2001;61:6945-6951.
10. Maass N, Biallek M, Rosel F, et al. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 2002;297:125-128.
11. Domann FE, Rice JC, Hendrix MJ, Futscher BW. Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 2000;85:805-810.
12. Ding Y, Lee JF, Lu H, Lee MH, Yan DH. Interferon-inducible protein IFlXalpha1 functions as a negative regulator of H DM2. Mol Cell Biol 2006;26:1979-1996.
13. Liu Z, Shi HY, Nawaz Z, Zhang M. Tamoxifen induces the expression of maspin through estrogen receptor-alpha. Cancer Lett 2004;209:55-65.
14. Li X, Yin S, Meng Y, Sakr W, Sheng S. Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res 2006;66:9323-9329.
15. Marks P, Rifkind RA, Richon VM, Breslow R, Miller T, Kelly WK. Histone deacetylases and cancer: Causes and therapies. Nat Rev Cancer 2001;1:194-202.
16. Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: Molecular mechanisms of action. Oncogene 2007;26:5541-5552.
17. Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006;5:769-784.
18. Senese S, Zaragoza K, Minardi S, et al. Role for histone deacetylase 1 in human tumor cell proliferation. Mol Cell Biol 2007;27:4784-4795.
19. Marks PA, Breslow R. Dimethyl sulfoxide to vorinostat: Development of this histone deacetylase inhibitor as an anticancer drug. Nat Biotechnol 2007;25:84-90.
20. Li X, Chen D, Yin S, et al. Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. J Cell Physiol 2007;212:298-306.